Clinical Trial Update: Metformin Plus Irinotecan for Refractory Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of metformin and irinotecan for refractory colorectal cancer; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• metformin (metformin)

Snippet

Sponsor: Barretos Cancer Hospital | Conditions: Colorectal Neoplasms, Adenocarcinoma | Phase 2 | Status: UNKNOWN